Viatris Innovation GmbH
Clinical trials sponsored by Viatris Innovation GmbH, explained in plain language.
A German subsidiary of Viatris, a global healthcare company making generic and branded medicines.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New blood thinner tested in small chinese heart study Results expected Oct 2026 (estimated)
- New lupus pill shows promise in major trial Results expected Dec 2026 (estimated)
- New pill could tame lupus flares in major trial Results expected Mar 2027 (estimated)
- Could a Pen-Sized shot stop a heart attack in its tracks? Results expected Jul 2027 (estimated)